Christopher L. Morton
- Molecular Biology top 2%
- Oncology top 2%
- Pharmacology top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Neurology top 1%
- Co-authors
- Peter J. HoughtonPhilip M. PotterMary K. DanksMalcolm A. SmithC. Patrick ReynoldsJohn M. MarisStephen T. KeirE. Anders Kolb
- Topics
- Neuroblastoma Research and Treatments (31 papers)Cancer therapeutics and mechanisms (30 papers)Cholinesterase and Neurodegenerative Diseases (19 papers)
- Cited by
- OncologyPharmacologyNeurology
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Christopher L. Morton
127 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 3.2k
- Oncology 1.5k
- Pharmacology 935
- Pulmonary and Respiratory Medicine 915
- Neurology 814
Countries citing papers authored by Christopher L. Morton
This map shows the geographic impact of Christopher L. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Morton more than expected).
Fields of papers citing papers by Christopher L. Morton
This network shows the impact of papers produced by Christopher L. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Morton. The network helps show where Christopher L. Morton may publish in the future.
Co-authorship network of co-authors of Christopher L. Morton
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Morton. A scholar is included among the top collaborators of Christopher L. Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Morton. Christopher L. Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs | 1 |
| 5 | 27 | |
| 6 | 34 | |
| 7 | 79 | |
| 8 | 132 | |
| 9 | 44 | |
| 10 | 26 | |
| 11 | 95 | |
| 12 | Pediatric preclinical testing program (PPTP) evaluation of the MEK1/2 inhibitor AZD6244 (ARRY-142886) | 1 |
| 13 | 91 | |
| 14 | Pediatric preclinical testing program (PPTP) evaluation of the fully human anti-IGF-1R antibody SCH 717454 | 1 |
| 15 | Combination of CP-751871, a human monoclonal antibody against the IGF-1 receptor, with rapamycin results in a highly effective therapy for xenografts derived from childhood sarcomas | 6 |
| 16 | Pediatric preclinical testing program (PPTP) evaluation of the EGFR and ErbB2 inhibitor lapatinib | 1 |
| 17 | 98 | |
| 18 | 122 | |
| 19 | Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies. | 14 |
| 20 | Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients. | 27 |
About Christopher L. Morton
Christopher L. Morton is a scholar working on Neurology, Molecular Biology and Pharmacology, having authored 128 papers that have together received 5.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (31 papers), Cancer therapeutics and mechanisms (30 papers) and Cholinesterase and Neurodegenerative Diseases (19 papers). The work is most often cited by research in Oncology (1.5k citations), Pharmacology (935 citations) and Neurology (814 citations). Christopher L. Morton has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Peter J. Houghton, Philip M. Potter, Mary K. Danks, Malcolm A. Smith, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, E. Anders Kolb, Richard Görlick and Richard B. Lock. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.